Oral D-mannose in recurrent urinary tract infections in women: A pilot study

D. Porru, A. Parmigiani, C. Tinelli, D. Barletta, D. Choussos, C. Di Franco, V. Bobbi, S. Bassi, O. Miller, B. Gardella, R. E. Nappi, A. Spinillo, B. Rovereto

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: In recurrent urinary tract infections (UTIs) usual prophylactic antibiotic regimes do not change the long-term risk of recurrence. Our aim was to evaluate the efficacy of D-mannose in the treatment and prophylaxis of recurrent UTIs. Methods: In this randomized cross-over trial female patients were eligible for the study if they had an acute symptomatic UTI and three or more recurrent UTIs during the preceding 12 months. Suitable patients were randomly assigned to antibiotic treatment with trimethoprim/sulfamethoxazole or to a regimen of oral D-mannose 1 g 3 times a day, every 8 hours for 2 weeks, and subsequently 1 g twice a day for 22 weeks. They received the other intervention in the second phase of the study, with no further antibiotic prophylaxis. The primary endpoint was evaluation of the elapsed time to recurrence; secondary endpoints were evaluation of bladder pain (VASp) and urinary urgency (VASu). Results: The results for quantitative variables were expressed as mean values and SD as they were all normally distributed (Shapiro-Wilk test). In total, 60 patients aged between 22 and 54 years (mean 42 years) were included. Mean time to UTI recurrence was 52.7 days with antibiotic treatment, and 200 days with oral D-mannose (p <0.0001). Conclusions: Mean VASp, VASu score, and average numbers of 24-hour voidings decreased significantly. D-mannose appeared to be a safe and effective treatment for recurrent UTIs in adult women. A significant difference was observed in the proportion of women remaining infection free versus antibiotic treatment.

Original languageEnglish
Pages (from-to)208-213
Number of pages6
JournalJournal of Clinical Urology
Volume7
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Mannose
Urinary Tract Infections
Anti-Bacterial Agents
Recurrence
Therapeutics
Antibiotic Prophylaxis
Sulfamethoxazole Drug Combination Trimethoprim
Cross-Over Studies
Urinary Bladder
Pain
Infection

Keywords

  • Antibiotic treatment
  • cystitis
  • D-mannose
  • prophylaxis
  • recurrent urinary tract infections

ASJC Scopus subject areas

  • Surgery
  • Urology

Cite this

Oral D-mannose in recurrent urinary tract infections in women : A pilot study. / Porru, D.; Parmigiani, A.; Tinelli, C.; Barletta, D.; Choussos, D.; Di Franco, C.; Bobbi, V.; Bassi, S.; Miller, O.; Gardella, B.; Nappi, R. E.; Spinillo, A.; Rovereto, B.

In: Journal of Clinical Urology, Vol. 7, No. 3, 2014, p. 208-213.

Research output: Contribution to journalArticle

@article{86fef2cdc3e8476197a62bb572aa5a6b,
title = "Oral D-mannose in recurrent urinary tract infections in women: A pilot study",
abstract = "Background: In recurrent urinary tract infections (UTIs) usual prophylactic antibiotic regimes do not change the long-term risk of recurrence. Our aim was to evaluate the efficacy of D-mannose in the treatment and prophylaxis of recurrent UTIs. Methods: In this randomized cross-over trial female patients were eligible for the study if they had an acute symptomatic UTI and three or more recurrent UTIs during the preceding 12 months. Suitable patients were randomly assigned to antibiotic treatment with trimethoprim/sulfamethoxazole or to a regimen of oral D-mannose 1 g 3 times a day, every 8 hours for 2 weeks, and subsequently 1 g twice a day for 22 weeks. They received the other intervention in the second phase of the study, with no further antibiotic prophylaxis. The primary endpoint was evaluation of the elapsed time to recurrence; secondary endpoints were evaluation of bladder pain (VASp) and urinary urgency (VASu). Results: The results for quantitative variables were expressed as mean values and SD as they were all normally distributed (Shapiro-Wilk test). In total, 60 patients aged between 22 and 54 years (mean 42 years) were included. Mean time to UTI recurrence was 52.7 days with antibiotic treatment, and 200 days with oral D-mannose (p <0.0001). Conclusions: Mean VASp, VASu score, and average numbers of 24-hour voidings decreased significantly. D-mannose appeared to be a safe and effective treatment for recurrent UTIs in adult women. A significant difference was observed in the proportion of women remaining infection free versus antibiotic treatment.",
keywords = "Antibiotic treatment, cystitis, D-mannose, prophylaxis, recurrent urinary tract infections",
author = "D. Porru and A. Parmigiani and C. Tinelli and D. Barletta and D. Choussos and {Di Franco}, C. and V. Bobbi and S. Bassi and O. Miller and B. Gardella and Nappi, {R. E.} and A. Spinillo and B. Rovereto",
year = "2014",
doi = "10.1177/2051415813518332",
language = "English",
volume = "7",
pages = "208--213",
journal = "Journal of Clinical Urology",
issn = "2051-4158",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Oral D-mannose in recurrent urinary tract infections in women

T2 - A pilot study

AU - Porru, D.

AU - Parmigiani, A.

AU - Tinelli, C.

AU - Barletta, D.

AU - Choussos, D.

AU - Di Franco, C.

AU - Bobbi, V.

AU - Bassi, S.

AU - Miller, O.

AU - Gardella, B.

AU - Nappi, R. E.

AU - Spinillo, A.

AU - Rovereto, B.

PY - 2014

Y1 - 2014

N2 - Background: In recurrent urinary tract infections (UTIs) usual prophylactic antibiotic regimes do not change the long-term risk of recurrence. Our aim was to evaluate the efficacy of D-mannose in the treatment and prophylaxis of recurrent UTIs. Methods: In this randomized cross-over trial female patients were eligible for the study if they had an acute symptomatic UTI and three or more recurrent UTIs during the preceding 12 months. Suitable patients were randomly assigned to antibiotic treatment with trimethoprim/sulfamethoxazole or to a regimen of oral D-mannose 1 g 3 times a day, every 8 hours for 2 weeks, and subsequently 1 g twice a day for 22 weeks. They received the other intervention in the second phase of the study, with no further antibiotic prophylaxis. The primary endpoint was evaluation of the elapsed time to recurrence; secondary endpoints were evaluation of bladder pain (VASp) and urinary urgency (VASu). Results: The results for quantitative variables were expressed as mean values and SD as they were all normally distributed (Shapiro-Wilk test). In total, 60 patients aged between 22 and 54 years (mean 42 years) were included. Mean time to UTI recurrence was 52.7 days with antibiotic treatment, and 200 days with oral D-mannose (p <0.0001). Conclusions: Mean VASp, VASu score, and average numbers of 24-hour voidings decreased significantly. D-mannose appeared to be a safe and effective treatment for recurrent UTIs in adult women. A significant difference was observed in the proportion of women remaining infection free versus antibiotic treatment.

AB - Background: In recurrent urinary tract infections (UTIs) usual prophylactic antibiotic regimes do not change the long-term risk of recurrence. Our aim was to evaluate the efficacy of D-mannose in the treatment and prophylaxis of recurrent UTIs. Methods: In this randomized cross-over trial female patients were eligible for the study if they had an acute symptomatic UTI and three or more recurrent UTIs during the preceding 12 months. Suitable patients were randomly assigned to antibiotic treatment with trimethoprim/sulfamethoxazole or to a regimen of oral D-mannose 1 g 3 times a day, every 8 hours for 2 weeks, and subsequently 1 g twice a day for 22 weeks. They received the other intervention in the second phase of the study, with no further antibiotic prophylaxis. The primary endpoint was evaluation of the elapsed time to recurrence; secondary endpoints were evaluation of bladder pain (VASp) and urinary urgency (VASu). Results: The results for quantitative variables were expressed as mean values and SD as they were all normally distributed (Shapiro-Wilk test). In total, 60 patients aged between 22 and 54 years (mean 42 years) were included. Mean time to UTI recurrence was 52.7 days with antibiotic treatment, and 200 days with oral D-mannose (p <0.0001). Conclusions: Mean VASp, VASu score, and average numbers of 24-hour voidings decreased significantly. D-mannose appeared to be a safe and effective treatment for recurrent UTIs in adult women. A significant difference was observed in the proportion of women remaining infection free versus antibiotic treatment.

KW - Antibiotic treatment

KW - cystitis

KW - D-mannose

KW - prophylaxis

KW - recurrent urinary tract infections

UR - http://www.scopus.com/inward/record.url?scp=84899679178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899679178&partnerID=8YFLogxK

U2 - 10.1177/2051415813518332

DO - 10.1177/2051415813518332

M3 - Article

AN - SCOPUS:84899679178

VL - 7

SP - 208

EP - 213

JO - Journal of Clinical Urology

JF - Journal of Clinical Urology

SN - 2051-4158

IS - 3

ER -